Topics › Life Sciences › Immunology and Microbiology › Immunology
Complement system in diseases Sign in to save
Papers per year
Papers 197
Open in paper search →-
Long-term safety and efficacy of iptacopan in patients with paroxysmal nocturnal hemoglobinuria: 4- and 5-year follow-up of patients from Phase 2 studies who entered the roll-over extension program
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre-de-Fontbrune, +8 more
0citations -
The 2-year efficacy and safety of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria with a history of aplastic anemia on concomitant immunosuppressive therapy who entered the roll-over extension program2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Anna Gayà, Morag Griffin, Bing Han, Austin Gladston Kulasekararaj, Jaroslaw Pawel Maciejewski, +11 more
0citations -
Apply-PNH: Analysis of complement pathway biomarkers provides evidence for pharmacodynamic response in PNH patients who receive oral iptacopan monotherapy versus continuing anti-C5 therapy2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Richard Kelly, Austin Gladston Kulasekararaj, Alexander Röth, Phillip Scheinberg, Yasutaka Ueda, +4 more
0citations -
Oral iptacopan monotherapy demonstrates clinically meaningful hemoglobin increases in patients with paroxysmal nocturnal hemoglobinuria with baseline hemoglobin levels 10 to <12 g/dl on anti-C5 therapy: Subgroup analysis of the appulse-pnh Phase 3b trial2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Austin Gladston Kulasekararaj, Flore Sicre-de-Fontbrune, Anna Gayà, Ilene Ceil Weitz, David J. Kuter, David J. Araten, +15 more
0citations -
Reply to the correspondence on ‘Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens’2026 Annals of the Rheumatic Diseases letter Immunology and Microbiology Complement system in diseases
Haiyu Wang, Saskia Nugteren, Rick J. Groenland, Stef van der Meulen, Hanneke Kapsenberg, Christoph Gstöttner, +5 more
0citations -
WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS2026 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access
David John Kavanagh, Andrew S. Bomback, Carla M. Nester, Richard J.H. Smith, Liz Lightstone, Marina Vivarelli, +8 more
0citations -
Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp2026 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access
Lieke ter Steeg, Romy N. Bouwmeester, Mendy ter Avest, Fréderike J. Bemelman, Antonia H. M. Bouts, O.W. Bredewold, +18 more
0citations -
Management of recurrent C3 glomerulopathy after kidney transplantation2026 Nephrology Dialysis Transplantation article Immunology and Microbiology Complement system in diseases Open access
Hernando Trujillo, Teresa Cavero, Sarah Margaret Moran, Şafak Mirioğlu, Annette N. Bruchfeld, Stefanie Steiger, +7 more
0citations -
MDS-1159: Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Immunology and Microbiology Complement system in diseases
Alexander Röth, Austin Gladston Kulasekararaj, Camilla Frieri, Flore Sicre de Fontbrune, Phillip Scheinberg, Bor‐Sheng Ko, +8 more
0citations -
POSTER: MDS-1167: Long-Term Hematologic Control and Safety in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Iptacopan: Six-Year Follow-Up From Phase 2 Studies and Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre de Fontbrune, +8 more
0citations -
POSTER: MDS-1159: Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Alexander Röth, Austin GKulasekararaj, Camilla Frieri, Flore Sicre de Fontbrune, Phillip Scheinberg, Bor‐Sheng Ko, +8 more
0citations -
MDS-1167: Long-Term Hematologic Control and Safety in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Iptacopan: Six-Year Follow-Up From Phase 2 Studies and Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Immunology and Microbiology Complement system in diseases
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre de Fontbrune, +8 more
0citations
Most active Aachen authors
-
Jens Panse 10,288 citations overall71 papers
-
Régis Peffault de Latour 20,463 citations overall20 papers
-
Leendert Adrianus Trouw 13,728 citations overall20 papers
-
Antonio Maria Risitano 16,882 citations overall16 papers
-
Mohamed R. Daha 31,961 citations overall10 papers
-
Cees van Kooten 25,919 citations overall10 papers
-
Austin Gladston Kulasekararaj 11,908 citations overall9 papers
-
Flore Sicre de Fontbrune 6,345 citations overall8 papers
-
Thomas Harry Sharp 3,049 citations overall8 papers
-
Mieke F. van Essen 744 citations overall8 papers
-
Anja Mühlfeld 2,409 citations overall7 papers
-
Paul W.H.I. Parren 32,989 citations overall6 papers
-
Haiyu Wang 1,710 citations overall6 papers
-
Douwe J. Dijkstra 371 citations overall6 papers
-
Leoni Abendstein 215 citations overall6 papers